Renal stones, timing hypothesis, and eu-estrogenemia
- PMID: 21892110
- DOI: 10.1097/gme.0b013e318221be9b
Renal stones, timing hypothesis, and eu-estrogenemia
Abstract
Objective: The aim of this study was to apply the theory of the timing hypothesis to the data presented on the incidence of renal stones in the Women's Health Initiative and the theory of eu-estrogenemia.
Methods: The study is a review of the literature on the theory of renal stone formation and postmenopausal women, including data from the Nurses' Health Study and the Women's Health Initiative.
Results: The analysis of the hazard ratios and CIs of renal stones in the Women's Health Initiative shows that specific subgroups are affected. The CIs of the hazard ratios did not overlap 1.0 in the 60- to 64-year-old age group and in women whose time since menopause at study entry was 6 to 10 years. The CIs of all other age groups and years from menopause overlapped 1.0. Hormone therapy use by women described as "current users" at time of entry into the study in the treatment had a hazard ratio of 0.99.
Conclusions: The timing hypothesis of Clarkson (Menopause 14:373-384; 2007) seems to explain the hazard ratio and CI of renal stones in the Women's Health Initiative. A closer analysis of the subgroups of women who had a higher incidence of renal stones suggests that the timing hypothesis may explain the results from the Women's Health Initiative versus previous studies such as the Nurses' Health Study. The CIs of the hazard ratios of the subgroups that did not overlap 1.0 included women 6 to 10 years beyond menopause, those who were aged from 60 to 64 years, and "never users" of hormone therapy. The hazard ratio for renal stones among "current users" in the Women's Health Initiative was 0.99. This analysis suggests that the timing hypothesis may affect estrogen receptor-α-mediated processes in the kidney. Furthermore, Clarkson's work may support the vascular etiology of renal stones.
Similar articles
-
Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.J Womens Health (Larchmt). 2006 Jan-Feb;15(1):35-44. doi: 10.1089/jwh.2006.15.35. J Womens Health (Larchmt). 2006. PMID: 16417416
-
Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.Am J Epidemiol. 2009 Jul 1;170(1):24-8. doi: 10.1093/aje/kwp113. Epub 2009 May 25. Am J Epidemiol. 2009. PMID: 19468078
-
Menopause and stroke and the effects of hormonal therapy.Climacteric. 2007 Oct;10 Suppl 2:27-31. doi: 10.1080/13697130701550903. Climacteric. 2007. PMID: 17882669 Review.
-
Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.Am J Epidemiol. 2005 Sep 1;162(5):404-14. doi: 10.1093/aje/kwi223. Epub 2005 Jul 20. Am J Epidemiol. 2005. PMID: 16033876
-
A comparative review of the risks and benefits of hormone replacement therapy regimens.Am J Obstet Gynecol. 2004 Apr;190(4):1141-67. doi: 10.1016/j.ajog.2003.09.033. Am J Obstet Gynecol. 2004. PMID: 15118656 Review.
Cited by
-
A theory of eu-estrogenemia: a unifying concept.Menopause. 2017 Sep;24(9):1086-1097. doi: 10.1097/GME.0000000000000895. Menopause. 2017. PMID: 28562489 Free PMC article. Review.
-
Network pharmacology and experimental validation to elucidate the pharmacological mechanisms of Bushen Huashi decoction against kidney stones.Front Endocrinol (Lausanne). 2023 Feb 14;14:1031895. doi: 10.3389/fendo.2023.1031895. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36864834 Free PMC article.
-
The Protective Roles of Estrogen Receptor β in Renal Calcium Oxalate Crystal Formation via Reducing the Liver Oxalate Biosynthesis and Renal Oxidative Stress-Mediated Cell Injury.Oxid Med Cell Longev. 2019 Apr 17;2019:5305014. doi: 10.1155/2019/5305014. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31178964 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical